A newly approved ‘living drug’ could save more cancer patients’ lives

Tumor-infiltrating lymphocyte, or TIL, therapy is the first T cell treatment for solid tumors. It fights melanoma and maybe other cancers too.

Aug 22, 2024 - 19:00
 0  15
A newly approved ‘living drug’ could save more cancer patients’ lives
Tumor-infiltrating lymphocyte, or TIL, therapy is the first T cell treatment for solid tumors. It fights melanoma and maybe other cancers too.